On ECHEMI
Home > Drugs > HUA-YU (WUXI) Pharmaceutical Co., Ltd.
HUA-YU (WUXI) Pharmaceutical Co., Ltd.
  • Founded in:

    1993-01-19
  • Country:

    China China
  • Address:

    2nd Floor, Building 7, Phase II, Biomedical R&D Service Outsourcing Zone, No. 138 Meiliang Road, Mashan, Wuxi
  • Tax NO.:

    91320200607912858J
  • Registered Funds:

    $20 million
  • Website:

  • Email:

Related Drugs
Sodium Chloride Injection
This product is an isotonic sterilized aqueous solution of sodium chloride. The sodium chloride (NaCl) content should be 0.850% to 0.950% (g/ml).
Name Description Content CAS NO. Registered Holders
Sodium chloride

Sodium and chloride are important electrolytes in the body, mainly existing in extracellular fluid, and play a very important role in maintaining normal blood and extracellular fluid volume and osmotic pressure. The normal serum sodium concentration is 135-145mmol/L, accounting for 92% of plasma cations and 90% of total osmotic pressure. Therefore, the amount of plasma sodium plays a decisive role in osmotic pressure. The normal serum chloride concentration is 98-106mmol/L. Sodium and chloride ions in the human body are mainly regulated by the hypothalamus, posterior pituitary and kidneys to maintain the stability of body fluid volume and osmotic pressure.

More

Sodium and chloride are important electrolytes in the body, mainly existing in extracellular fluid, and play a very important role in maintaining normal blood and extracellular fluid volume and osmotic pressure. The normal serum sodium concentration is 135-145mmol/L, accounting for 92% of plasma cations and 90% of total osmotic pressure. Therefore, the amount of plasma sodium plays a decisive role in osmotic pressure. The normal serum chloride concentration is 98-106mmol/L. Sodium and chloride ions in the human body are mainly regulated by the hypothalamus, posterior pituitary and kidneys to maintain the stability of body fluid volume and osmotic pressure.

0.850~0.950g/ml 7647-14-5 43
Isofuranamide Tablets
This product is a compound preparation, each tablet contains the active ingredients rifampicin 0.12g, isoniazid 0.08g, and pyrazinamide 0.25g.
Name Description Content CAS NO. Registered Holders
Rifampicin

It has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae, etc.) both inside and outside the host cells.

More

It has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae, etc.) both inside and outside the host cells.

0.12g 13292-46-1 24
Isoniazid

Anti-tuberculosis drugs are a combination of rifampicin, isoniazid and pyrazinamide. Rifampicin has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae) both inside and outside the host cells.

More

Anti-tuberculosis drugs are a combination of rifampicin, isoniazid and pyrazinamide. Rifampicin has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae) both inside and outside the host cells.

0.08g 54-85-3 20
Pyrazinamide

Anti-tuberculosis drugs are a combination of rifampicin, isoniazid and pyrazinamide. Rifampicin has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae) both inside and outside the host cells.

More

Anti-tuberculosis drugs are a combination of rifampicin, isoniazid and pyrazinamide. Rifampicin has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae) both inside and outside the host cells.

0.25g 98-96-4 21
Yifu Tablets
This product is a compound preparation, the active ingredients of which are rifampicin and isoniazid.
Name Description Content CAS NO. Registered Holders
Rifampicin

It has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae, etc.) both inside and outside the host cells. It firmly binds to the beta subunit of the DNA-dependent RNA polymerase, inhibits the synthesis of bacterial RNA, prevents the enzyme from connecting to DNA, thereby blocking the RNA transcription process and stopping the synthesis of DNA and protein.

More

It has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae, etc.) both inside and outside the host cells. It firmly binds to the beta subunit of the DNA-dependent RNA polymerase, inhibits the synthesis of bacterial RNA, prevents the enzyme from connecting to DNA, thereby blocking the RNA transcription process and stopping the synthesis of DNA and protein.

13292-46-1 24
Isoniazid

It has a highly selective bactericidal effect on all types of Mycobacterium tuberculosis, with a strong effect on Mycobacterium tuberculosis in the growth and reproduction stage, and a weaker and slower effect on Mycobacterium tuberculosis in the dormant stage. The mechanism of action may be to inhibit the synthesis of mycolic acid in sensitive bacteria and cause the cell wall to rupture.

More

It has a highly selective bactericidal effect on all types of Mycobacterium tuberculosis, with a strong effect on Mycobacterium tuberculosis in the growth and reproduction stage, and a weaker and slower effect on Mycobacterium tuberculosis in the dormant stage. The mechanism of action may be to inhibit the synthesis of mycolic acid in sensitive bacteria and cause the cell wall to rupture.

54-85-3 20
Ciclopirox olamine cream
Each gram of this product contains 10 mg of the main ingredient, ciclopirox olamine. The excipients are octadecyl alcohol, stearic acid, white vaseline, Span-60, dimethicone, propylene glycol, glycerin, Tween-80, benzoic acid, menthol, S-40, isopropyl palmitate, lactic acid, medicinal ethanol, and water.
Name Description Content CAS NO. Registered Holders
Ciclopirox ethanolamine

This product is a broad-spectrum antifungal drug. It mainly changes the integrity of fungal cell membranes, causes the outflow of intracellular substances, and blocks the uptake of protein precursor substances, leading to fungal cell death. It has strong antibacterial and bactericidal effects on dermatophytes, yeasts, molds, etc., and has strong permeability. It also has a certain inhibitory effect on various actinomycetes, Gram-positive and Gram-negative bacteria, mycoplasmas, chlamydia, Trichomonas, etc.

More

This product is a broad-spectrum antifungal drug. It mainly changes the integrity of fungal cell membranes, causes the outflow of intracellular substances, and blocks the uptake of protein precursor substances, leading to fungal cell death. It has strong antibacterial and bactericidal effects on dermatophytes, yeasts, molds, etc., and has strong permeability. It also has a certain inhibitory effect on various actinomycetes, Gram-positive and Gram-negative bacteria, mycoplasmas, chlamydia, Trichomonas, etc.

10mg 41621-49-2 12
Urapidil
Name Description Content CAS NO. Registered Holders
6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyluracil

Extract from the above information

More

Extract from the above information

34661-75-1 9
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.